Sewaren Innovative Pharmaceutical Packaging Dba SIPP FDA Inspection Record

FEI 3012292690 · Inspections, Form 483s, warning letters and import refusals

Sewaren Innovative Pharmaceutical Packaging Dba SIPP is an FDA-inspected facility (FEI 3012292690) located in Avenel, NJ, US. RegDataLab tracks 1 FDA inspection and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Jun 28, 2016: Official Action Indicated (OAI)
Inspections on record
1 (1 OAI)
Last OAI inspection
Jun 28, 2016
Warning letters
1 listed by FDA for this FEI, latest May 22, 2017
Form 483 and inspection documents
1 in FDA's reading room

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 28, 2016Official Action Indicated (OAI)Validation lacking for sterile drug products (21 CFR 211.113(b))
Expiration date lacking (21 CFR 211.137(a))
Testing and release for distribution (21 CFR 211.165(a))

Form 483s and inspection documents

  • 483 on FDA.gov
    Inspection Apr 18, 2016 to Jun 28, 2016 (dates printed on the document). FDA listing date Jul 19, 2016. Published by FDA Jan 18, 2024.

FDA record score

8 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

2 records behind this number
RecordDatePoints x age weightAdds
Warning letter on FDA's dashboard, which does not show close-outsMay 22, 201730 x 0.257.5
Inspection classified OAIJun 28, 201610 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Sewaren Innovative Pharmaceutical Packaging Dba SIPP as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Sewaren Innovative Pharmaceutical Packaging Dba SIPP yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Sewaren Innovative Pharmaceutical Packaging
Location
Avenel, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.